Conference abstract · 2020
Conference abstractPublished 26 Jun 2014
Acute renal failure after therapy with Interferon
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: The main reason for the presentation of this clinical case is to attract attention of the dangerous possible risks of the therapy with Interferon at the patients with chronic hepatitis virus B or virus C positive who follow this protocol of therapy. Material and Methods: A clinical case where a patient aged 48 years old was hospitalized for the diagnosis of active chronic hepatitis with virus B positive with increase value of liver enzymes (TGO=248UI/l, TGP=342UI/l, Gama GT=121, indirect bilirubin=2,32, total bilirubin=3mg/dl, viremia=6 millions unites, AgHBs+, liver biopsy with histopathology examination confirmed active chronic hepatitis, summary of the urine revealed - presence of urobilinogen, proteinuria, absence of glucose and found to have normal urinary sediment, the value of urea=32mg/dl and creatinine=0.9mg/dl. After the patient followed with the protocol of therapy with @Interferon 3MU 3 times/week during three weeks presented the apparition of a palpable purpuric rash at the lower limbs and the nephritic syndrome was accented: proteinuria=30mg/dl, hematuria=20g/dl. After the skin biopsy was performed the result confirmed safe diagnosis of polyarteritis nodosa. The histopathological examination with fibrinoid necrosis of the vessel wall with surrounding perivascular lymphocytic infiltrates, polyarteritis nodosa was confirmed as the safe diagnosis. After that the patient developed a syndrome of progressive azotized retention uremia with increase level of creatinemia=5,08mg/dl and urea=402mg/dl with anuria so an acute renal failure in context of systemic vasculitis with secondary nephropathies hence an imposition of dialysis for the normalization of the azotized parameters. Histopathological examination after kidney biopsy revealed secondary subacute glomerulonephritis in context of systemic vasculitis. Results and Discussions: The patients with chronic hepatitis virus B or virus C positive is possible to have a systemic vasculitis in the context of the disease without clinical manifestations (subclinical) unknown and with secondary nephropathy in this context with minimal nephritic syndrome manifested with isolated proteinuria, isolated hematuria or proteinuria and hematuria identify after summary urine examination was performed. If the patient had this result with nephritic syndrome after urine examination before she start the therapy with @Interferon for active chronic hepatitis with virus C or B positive, the patient has risk to develop after the protocol therapy sub acute or acute renal failure with severe evolution of the patient with rapid progressive azotes retention syndrome to necessary dialysis for the patients. Conclusion: We must monitor very carefully the kidney function with the azotized parameters every day if the patient follow the protocol of therapy with @Interferon for active chronic virus B hepatitis because in context of unknown (subclinical) systemic vasculitis with a secondary glomerulonephritis the patient with virus B positive is possible to develop sudden and unexpected acute renal failure and dialysis is necessary
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Case report · 25 Oct 2018
Retinal Lesions and Renal Impairment Associated with Interferon β1α Therapy for Multiple Sclerosis: A Case Report
Letter · 7 Oct 2024
Relapsing Nephrotic Syndrome with Acute Renal Failure Following a Unique Episode of Multiple Bee Stings: A Letter to Editor
Rapid communication · 29 Jun 2023
Clinical presentation and diagnostic challenges of mycoplasma pneumoniae-associated acute renal failure
Short communication · 30 Dec 2022
Treatment for acute renal failure in children
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Manuela Stoicescu”

